Cargando…

Clinical landscape of TP73 structural variants in ATL patients

Detalles Bibliográficos
Autores principales:	Hiramatsu, Hiroaki, Yokomori, Rui, Shengyi, Liu, Tanaka, Norio, Mori, Seiichi, Kiyotani, Kazuma, Gotoh, Osamu, Kusumoto, Shigeru, Nakano, Nobuaki, Suehiro, Youko, Ito, Asahi, Choi, Ilseung, Ohtsuka, Eiichi, Hidaka, Michihiro, Nosaka, Kisato, Yoshimitsu, Makoto, Imaizumi, Yoshitaka, Iida, Shinsuke, Utsunomiya, Atae, Noda, Tetsuo, Nishikawa, Hiroyoshi, Ueda, Ryuzo, Sanda, Takaomi, Ishida, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681890/ https://www.ncbi.nlm.nih.gov/pubmed/37864123 http://dx.doi.org/10.1038/s41375-023-02059-9

Ejemplares similares

Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma
por: Tanaka, Norio, et al.
Publicado: (2022)

Landscape of immunoglobulin heavy chain γ gene class switch recombination in patients with adult T-cell leukemia–lymphoma
por: Hiramatsu, Hiroaki, et al.
Publicado: (2022)

Clinical significance of the immunoglobulin G heavy‐chain repertoire in peripheral blood mononuclear cells of adult T‐cell leukaemia–lymphoma patients receiving mogamulizumab
por: Nosaka, Kisato, et al.
Publicado: (2021)

The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes
por: Suehiro, Youko, et al.
Publicado: (2014)

Augmentation of donor-derived Tax-specific CTL responses by a novel Tax epitope-specific CD4+ helper T-cells in ATL patients after allogeneic hematopoietic stem cell transplantation
por: Hasegawa, Atsuhiko, et al.
Publicado: (2014)

Prospective studies of allogeneic hema topoietic stem cell transplantation for adult T-cell leukemia-lymphoma
por: Cho, Ilseung, et al.
Publicado: (2015)

Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
por: Utsunomiya, Atae, et al.
Publicado: (2011)

HTLV-1 modulates the frequency and phenotype of FoxP3(+)CD4(+) T cells in virus-infected individuals
por: Satou, Yorifumi, et al.
Publicado: (2012)

The kinetics of HTLV-1 proviral load after allogeneic hematopoietic cell transplantation with reduced intensity conditioning regimen; a comparison with that from sibling donors and that from unrelated donors
por: Choi, Ilseung, et al.
Publicado: (2014)

Disorders of the cMyb proto-oncogene expression and its significance in the course of ATL development
por: Nakano, Kazumi, et al.
Publicado: (2014)

Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL
por: Kannagi, Mari, et al.
Publicado: (2019)

Epidemiology of adult T‐cell leukemia‐lymphoma in Japan: An updated analysis, 2012‐2013
por: Ito, Shigeki, et al.
Publicado: (2021)

Long-term follow-up of patients with ATL after autologous stem cell transplantation
por: Utsunomiya, Atae, et al.
Publicado: (2022)

Sensitive detection and apoptotic cell death induction of adult T-cell leukemia/lymphoma (ATL) cells with photodynamic actions
por: Oka, Takashi, et al.
Publicado: (2014)

Clinical significance of tryptophan catabolism in Hodgkin lymphoma
por: Masaki, Ayako, et al.
Publicado: (2017)

Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study
por: Ito, Ayumu, et al.
Publicado: (2021)

Recent advances in the treatment of adult T-cell leukemia-lymphomas
por: Utsunomiya, Atae, et al.
Publicado: (2015)

Elderly ATL patients in ageing society of Japan
por: Takemoto, Shigeki, et al.
Publicado: (2011)

Overexpression of aberrant Wnt5a and its effect on acquisition of malignant phenotypes in adult T-cell leukemia/lymphoma (ATL) cells
por: Nakano, Kazumi, et al.
Publicado: (2021)

A phase II study of bortezomib in patients with relapsed or refractory aggressive adult T-cell leukemia/lymphoma
por: Ishitsuka, Kenji, et al.
Publicado: (2015)

Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level
por: Uike, Naokuni, et al.
Publicado: (2011)

ATL internals: working with ATL 8
por: Tavares, Chris
Publicado: (2006)

In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions
por: Izaki, Mikiko, et al.
Publicado: (2021)

Immunohistochemistry for CCR4 C‐terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T‐cell leukemia/lymphoma
por: Fujii, Keiichiro, et al.
Publicado: (2020)

Clinical significance of CD28 gene‐related activating alterations in adult T‐cell leukaemia/lymphoma
por: Sakamoto, Yuma, et al.
Publicado: (2020)

Clinicopathological significance of CD28 overexpression in adult T‐cell leukemia/lymphoma
por: Sakamoto, Yuma, et al.
Publicado: (2021)

Effect of a novel anti-CCR4 monoclonal antibody (Mogamulizmab) on skin lesions of adult T-cell leukemia-lymphoma (ATL) and its adverse skin reactions (ASR)
por: Yonekura, Kentaro, et al.
Publicado: (2014)

CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment
por: Sakamoto, Yuma, et al.
Publicado: (2022)

An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma
por: Izutsu, Koji, et al.
Publicado: (2023)

A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan
por: Ishizawa, Kenichi, et al.
Publicado: (2022)

Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study
por: Imaizumi, Yoshitaka, et al.
Publicado: (2020)

ATL internals
por: Rector, Brent, et al.
Publicado: (1999)

ATL internals /
por: Rector, Brent
Publicado: (1999)

Dr. Atl /
por: Luna Arroyo, Antonio
Publicado: (1992)

Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody
por: Sugata, Kenji, et al.
Publicado: (2016)

Epidemiological and clinical features of adult T‐cell leukemia–lymphoma in Japan, 2010–2011: A nationwide survey
por: Nosaka, Kisato, et al.
Publicado: (2017)

Can we cure ATL: new drugs and targeting ATL stem cells
por: Hermine, Olivier
Publicado: (2014)

Dr. Atl : pinturas y dibujos /
por: Atl, Dr., 1875-1964
Publicado: (1974)

Oral histone deacetylase inhibitor tucidinostat (HBI‐8000) in patients with relapsed or refractory adult T‐cell leukemia/lymphoma: Phase IIb results
por: Utsunomiya, Atae, et al.
Publicado: (2022)

Dr. Atl : el paisaje como pasión /
por: Espejo, Beatriz
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_bdtml01ul5d78edtfa500k2ak0